(Q37804379)

23 August 2017

title

New antimicrobial strategies in cystic fibrosis (English)

1 reference

23 August 2017

0 references

Mireille van Westreenen

series ordinal

1

1 reference

23 August 2017

Harm A W M Tiddens

series ordinal

2

1 reference

23 August 2017

publication date

1 December 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

12

1 reference

23 August 2017

issue

6

1 reference

23 August 2017

page(s)

343-352

1 reference

Prevention of chronic Pseudomonas aeruginosa infection in people with cystic fibrosis.

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F11316240-000000000-00000

Approaches to analyse dynamic microbial communities such as those seen in cystic fibrosis lung

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11316240-000000000-00000

Inactivation of human beta-defensins 2 and 3 by elastolytic cathepsins

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11316240-000000000-00000

Contribution of the C-8 substituent of DU-6859a, a new potent fluoroquinolone, to its activity against DNA gyrase mutants of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11316240-000000000-00000

Microparticles for inhalational delivery of antipseudomonal antibiotics

21 January 2018

1 reference

12 December 2020

Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis

1 reference

12 December 2020

Cospray dried antibiotics for dry powder lung delivery

1 reference

12 December 2020

Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial

1 reference

12 December 2020

Advanced nebulizer designs employing vibrating mesh/aperture plate technologies for aerosol generation.

1 reference

12 December 2020

Liposomal tobramycin against pulmonary infections of Pseudomonas aeruginosa: a pharmacokinetic and efficacy study following single and multiple intratracheal administrations in rats

1 reference

12 December 2020

Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii

1 reference

12 December 2020

Human pre-elafin inhibits a Pseudomonas aeruginosa-secreted peptidase and prevents its proliferation in complex media

1 reference

12 December 2020

The changing microbial epidemiology in cystic fibrosis

1 reference

12 December 2020

Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-pheno

1 reference

12 December 2020

Effect of dry powder inhaler resistance on the inspiratory flow rates and volumes of cystic fibrosis patients of six years and older.

1 reference

12 December 2020

Antimicrobial treatment of nosocomial meticillin-resistant Staphylococcus aureus (MRSA) pneumonia: current and future options

1 reference

12 December 2020

Protective effect of fosfomycin against aminoglycoside ototoxicity

1 reference

12 December 2020

In vitro activity of Iclaprim against respiratory and bacteremic isolates of Streptococcus pneumoniae

1 reference

12 December 2020

Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review

1 reference

12 December 2020

Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium.

1 reference

12 December 2020

Fosfomycin for Pseudomonas-related exacerbations of cystic fibrosis

1 reference

12 December 2020

Binding of protegrin-1 to Pseudomonas aeruginosa and Burkholderia cepacia

1 reference

12 December 2020

What's new and not so new on the antimicrobial horizon?

1 reference

12 December 2020

Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosis

1 reference

12 December 2020

Detection of Anaerobic Bacteria in High Numbers in Sputum from Patients with Cystic Fibrosis

1 reference

12 December 2020

Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients

1 reference

12 December 2020

Pulmonary drug delivery systems for antimicrobial agents: facts and myths.

1 reference

12 December 2020

Current status of newer carbapenems

1 reference

12 December 2020

Evaluation of long-term co-administration of tobramycin and clarithromycin in a mature biofilm model of cystic fibrosis clinical isolates of Pseudomonas aeruginosa.

1 reference

12 December 2020

Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: study of antibiotic combinations

1 reference

12 December 2020

Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid.

1 reference

12 December 2020

1 reference

12 December 2020

Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis.

1 reference

12 December 2020

Antimicrobial peptides and proteins in the innate defense of the airway surface

1 reference

12 December 2020

1 reference

12 December 2020

Phenotypic variability of Pseudomonas aeruginosa in sputa from patients with acute infective exacerbation of cystic fibrosis and its impact on the validity of antimicrobial susceptibility testing.

1 reference

12 December 2020

Reversal of resistance in microorganisms by help of non-antibiotics

1 reference

12 December 2020

Nontuberculous mycobacteria in the setting of cystic fibrosis

1 reference

12 December 2020

A three-dimensional computer model of four hypothetical mechanisms protecting biofilms from antimicrobials

1 reference

12 December 2020

In vitro activity of doripenem against Pseudomonas aeruginosa and Burkholderia cepacia isolates from both cystic fibrosis and non-cystic fibrosis patients

1 reference

12 December 2020

Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial

1 reference

12 December 2020

Novel tobramycin inhalation powder in cystic fibrosis subjects: pharmacokinetics and safety

1 reference

12 December 2020

In vitro and in vivo potency of polymyxin B against IMP-type metallo-beta-lactamase-producing Pseudomonas aeruginosa

1 reference

12 December 2020

Targeted drug delivery to enhance efficacy and shorten treatment duration in disseminated Mycobacterium avium infection in mice

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic evaluation of liposomal amikacin for inhalation in cystic fibrosis patients with chronic pseudomonal infection

1 reference

12 December 2020

Inhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic Fibrosis

1 reference

12 December 2020

Iron-binding compounds impair Pseudomonas aeruginosa biofilm formation, especially under anaerobic conditions

1 reference

12 December 2020

Preparation of macromolecule-containing dry powders for pulmonary delivery

1 reference

12 December 2020

The effect of recombinant human lactoferrin on growth and the antibiotic susceptibility of the cystic fibrosis pathogen Burkholderia cepacia complex when cultured planktonically or as biofilms

1 reference

12 December 2020

Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model

1 reference

12 December 2020

Inhibitors of bacterial efflux pumps as adjuvants in antibiotic treatments and diagnostic tools for detection of resistance by efflux

1 reference

12 December 2020

Relationship between antimicrobial proteins and airway inflammation and infection in cystic fibrosis

1 reference

12 December 2020

Shifting patterns of inhaled antibiotic use in cystic fibrosis

1 reference

12 December 2020

The incidence of anaerobes in the sputum of patients with cystic fibrosis

1 reference

12 December 2020

Recombinant human Monocyte/Neutrophil elastase inhibitor protects rat lungs against injury from cystic fibrosis airway secretions

1 reference

12 December 2020

In vitro activity of doripenem (S-4661) against multidrug-resistant gram-negative bacilli isolated from patients with cystic fibrosis

1 reference

12 December 2020

Mucoid Pseudomonas in cystic fibrosis

1 reference

12 December 2020

Transferrin and lactoferrin undergo proteolytic cleavage in the Pseudomonas aeruginosa-infected lungs of patients with cystic fibrosis.

1 reference

12 December 2020

In vitro activity of the aerosolized agents colistin and tobramycin and five intravenous agents against Pseudomonas aeruginosa isolated from cystic fibrosis patients in southwestern Germany

1 reference

12 December 2020

Fosfomycin – Investigation of a possible new route of administration of an old drug

1 reference

12 December 2020

A putative gene cluster for aminoarabinose biosynthesis is essential for Burkholderia cenocepacia viability

1 reference

12 December 2020

In vitro activity of minocycline against respiratory pathogens from patients with cystic fibrosis

1 reference

12 December 2020

A ten year review of colomycin

1 reference

12 December 2020

Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections

1 reference

12 December 2020

Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1.

1 reference

12 December 2020

Rapid pulmonary delivery of inhaled tobramycin for Pseudomonas infection in cystic fibrosis: a pilot project

1 reference

12 December 2020

Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis

1 reference

12 December 2020

Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients.

1 reference

12 December 2020

Antimicrobial proteins and peptides: anti-infective molecules of mammalian leukocytes

1 reference

12 December 2020

Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia

1 reference

12 December 2020

Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporin

1 reference

12 December 2020

Influence of taxonomic status on the in vitro antimicrobial susceptibility of the Burkholderia cepacia complex.

1 reference

12 December 2020

Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection

1 reference

12 December 2020

Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections

1 reference

12 December 2020

Successful treatment of cepacia syndrome

1 reference

12 December 2020

Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation

1 reference

12 December 2020

Microbial ecology of the cystic fibrosis lung

1 reference

12 December 2020

Elafin, an elastase-specific inhibitor, is cleaved by its cognate enzyme neutrophil elastase in sputum from individuals with cystic fibrosis

1 reference

12 December 2020

Physiological responses of Pseudomonas aeruginosa PAO1 to oxidative stress in controlled microaerobic and aerobic cultures

1 reference

12 December 2020

Bactericidal activity of mammalian cathelicidin-derived peptides.

1 reference

12 December 2020

Polymyxin B and colistimethate are comparable as to efficacy and renal toxicity.

1 reference

12 December 2020

Molecular Biology of Antibiotic Production in Bacillus

1 reference

12 December 2020

Approach to eradication of initial Pseudomonas aeruginosa infection in children with cystic fibrosis

1 reference

12 December 2020

Medical resource utilization among patients with ventilator-associated pneumonia: pooled analysis of randomized studies of doripenem versus comparators

1 reference

12 December 2020

Ionizing groups in lipopolysaccharides of Pseudomonas cepacia in relation to antibiotic resistance

1 reference

12 December 2020

Antimicrobial peptides in the airway.

1 reference

12 December 2020

Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients.

1 reference

12 December 2020

Efficacy of aerosol MP-376, a levofloxacin inhalation solution, in models of mouse lung infection due to Pseudomonas aeruginosa

1 reference

12 December 2020

Aminoglycoside antibiotics induce bacterial biofilm formation

1 reference

12 December 2020

Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum

1 reference

12 December 2020

Elafin (elastase-specific inhibitor) has anti-microbial activity against gram-positive and gram-negative respiratory pathogens

1 reference

12 December 2020

Microbiology, safety, and pharmacokinetics of aztreonam lysinate for inhalation in patients with cystic fibrosis

1 reference

12 December 2020

Dry powder inhalation of colistin in cystic fibrosis patients: a single dose pilot study.

1 reference

12 December 2020

A phase 2 study of aztreonam lysine for inhalation to treat patients with cystic fibrosis and Pseudomonas aeruginosa infection.

1 reference

12 December 2020

Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis

1 reference

12 December 2020

Fosfomycin therapy for multiresistant Pseudomonas aeruginosa in cystic fibrosis

1 reference

12 December 2020

Subinhibitory concentrations of the cationic antimicrobial peptide colistin induce the pseudomonas quinolone signal in Pseudomonas aeruginosa.

1 reference

12 December 2020

Four years' experience of intravenous colomycin in an adult cystic fibrosis unit

1 reference

12 December 2020

Co-encapsulation of gallium with gentamicin in liposomes enhances antimicrobial activity of gentamicin against Pseudomonas aeruginosa.

1 reference

12 December 2020

Deposition of aerosols in infants and children

1 reference

12 December 2020

Safety and tolerability of bolus intravenous colistin in acute respiratory exacerbations in adults with cystic fibrosis

1 reference

12 December 2020

Selected topics in novel methods of antibiotic delivery: aerosolized antibiotics and lipid preparations.

1 reference

12 December 2020

Changes in strategies for optimal antibacterial therapy in cystic fibrosis.

1 reference

12 December 2020

Vancomycin resistance in gram-positive cocci

1 reference

12 December 2020

Fosfomycin: use beyond urinary tract and gastrointestinal infections

1 reference

12 December 2020

Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa.

1 reference

12 December 2020

Multidrug-resistant pulmonary infection in cystic fibrosis--what does 'resistant' mean?

1 reference

12 December 2020

New antibiotics for healthcare-associated pneumonia

1 reference

12 December 2020

Eradication of mucoid Pseudomonas aeruginosa with fluid liposome-encapsulated tobramycin in an animal model of chronic pulmonary infection.

1 reference

12 December 2020

Efflux pumps as antimicrobial resistance mechanisms

1 reference

12 December 2020

Mode of protective action of fosfomycin against dibekacin-induced nephrotoxicity in the dehydrated rats

1 reference

12 December 2020

Bactericidal efficacy of liposomal aminoglycosides against Burkholderia cenocepacia.

1 reference

12 December 2020

The role and potential therapeutical applications of antimicrobial proteins in infectious and inflammatory diseases

1 reference

12 December 2020

10.2165/11316240-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

23 August 2017

1000441300

0 references

1 reference